| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 242,00 | 247,30 | 19.07. | |
| 243,50 | 245,30 | 17.07. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Can Onto Innovation Extend Its Winning Streak in Advanced Nodes Business? | 2 | Zacks | ||
| Di | Cantor Fitzgerald bestätigt Rating für Onto Innovation Aktie dank starker Produktzyklen | 2 | Investing.com Deutsch | ||
| Di | Cantor Fitzgerald reiterates Onto Innovation stock rating on product cycle strength | 1 | Investing.com | ||
| Di | Onto Innovation vs. Camtek: Which Inspection Stock is a Smarter Buy? | 1 | Zacks | ||
| 13.07. | Is Onto Innovation Gaining From Rising AI Semiconductor Demand? | 2 | Zacks | ||
| 10.07. | Onto Innovation (ONTO) Surpasses Market Returns: Some Facts Worth Knowing | 1 | Zacks | ||
| 08.07. | $1000 Invested In Onto Innovation 5 Years Ago Would Be Worth This Much Today | 1 | Benzinga.com | ||
| 22.06. | Oppenheimer raises Onto Innovation stock price target on AI platform strength | 33 | Investing.com | ||
| ONTO INNOVATION Aktie jetzt für 0€ handeln | |||||
| 17.06. | Freedom Broker initiates Onto Innovation stock coverage with buy rating | 7 | Investing.com | ||
| 17.06. | How is Onto Innovation Capitalizing on Advanced Packaging Demand? | 2 | Zacks | ||
| 16.06. | Onto Innovation (ONTO) Sees a More Significant Dip Than Broader Market: Some Facts to Know | 21 | Zacks | ||
| 15.06. | Morgan Stanley stuft Onto Innovation mit "Overweight" ein und sieht 15 % Kurspotenzial | 8 | Investing.com Deutsch | ||
| 15.06. | Morgan Stanley initiates Onto Innovation stock with overweight rating | 3 | Investing.com | ||
| 11.06. | Three Analysts Reaffirm Their Buy Ratings On Onto Innovation (ONTO) Stock | 13 | Insider Monkey | ||
| 05.06. | Wall Street Analysts Predict a 28.16% Upside in Onto Innovation (ONTO): Here's What You Should Know | 4 | Zacks | ||
| 05.06. | This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday | 3 | Benzinga.com | ||
| 05.06. | Deutsche Bank initiates Onto Innovation stock with buy rating on growth outlook | 11 | Investing.com | ||
| 05.06. | Wachstumsausblick überzeugt: Deutsche Bank startet Coverage für Onto Innovation mit "Buy" | 58 | Investing.com Deutsch | ||
| 04.06. | Stifel reiterates Onto Innovation stock rating on fast tool adoption | 3 | Investing.com | ||
| 04.06. | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | 11.677 | Xetra Newsboard | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 17,940 | +0,90 % | Formycon stärkt Biosimilar-Produktion mit OneSource | Formycon baut sein internationales Produktionsnetzwerk weiter aus. Der Biosimilar-Entwickler hat eine strategische Partnerschaft mit dem indischen CDMO OneSource Specialty Pharma geschlossen, um die... ► Artikel lesen | |
| KOPIN | 3,448 | +3,95 % | Fabric.AI (Nasdaq: FABC) Stockholders Ratify Kopin Strategic Partnership to Develop Neural I/o MicroLED Optical Interconnect Technology for Next Generation AI Data Centers | NEW YORK, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) ("Fabric.AI" or the "Company"), a fabless semiconductor company developing MicroLED-based optical interconnects for AI... ► Artikel lesen | |
| RIBER | 9,550 | 0,00 % | RIBER receives a new order from 3SP Technologies for a production platform | RIBER receives a new order from 3SP Technologies for a production platform Bezons (France), July 9, 2026 - 8:00 am (CET) - RIBER, a global market leader in molecular beam epitaxy (MBE) equipment for... ► Artikel lesen | |
| NVE | 76,00 | +0,66 % | Dividendenbekanntmachungen (18.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2A SPA IT0001233417 - 0,104 EUR AIR LIQUIDE SA FR0000120073 - 3,7 EUR ALCOA CORPORATION CDIS AU0000339426 0,1 USD 0,086 EUR ALLISON... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,169 | -2,03 % | SMOLTEK NANOTECH HOLDING AB: Smoltek joins MAXBATT together with industrial OEMs for scaling battery production | ||
| VEECO INSTRUMENTS | 47,000 | +2,82 % | Veeco Instruments Inc.: Veeco Reports First Quarter 2026 Financial Results | First Quarter 2026 Highlights: Revenue of $158.3 million, compared with $167.3 million in the same period last yearGAAP net loss of $(0.3) million, or $(0.01) loss per diluted share, compared with... ► Artikel lesen | |
| LAMPETIA | 0,180 | +38,46 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| GAUZY | 0,360 | 0,00 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F | TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on May 19, 2026... ► Artikel lesen | |
| GOMSPACE | 1,197 | +1,35 % | GomSpace A/S: GomSpace Signs 24.4 MSEK Contract with Unseenlabs | Unseenlabs extends its existing cube satellites constellation.STOCKHOLM, July 1, 2026 /PRNewswire/ -- Today, GomSpace has signed an additional contract with Unseenlabs to deliver two new... ► Artikel lesen | |
| SOLESENCE | 0,751 | -3,10 % | Solésence, Inc.: Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp | ||
| DOTZ NANO | 0,015 | -1,34 % | DOTZ NANO LIMITED: Results of Meeting | ||
| OBDUCAT | 0,049 | +25,13 % | NGM MARKET NOTICE: #26-16 Information regarding the last day of trading in paid subscribed units and the first day of trading in warrants issued by Obducat AB | ||
| NANOVIRICIDES | 1,570 | +2,61 % | As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo | SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,157 | +7,53 % | FendX Technologies Inc.: FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program | Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection... ► Artikel lesen | |
| ACACIA RESEARCH | 3,800 | 0,00 % | ACACIA RESEARCH CORP - 8-K, Current Report |